Increasing Diversity in European Clinical Trials

Sponsored by: Greenphire

Focused on:

  • Clinical Trials

Date: 18 March


Time: 3PM London / 4pm CET

How to Create Awareness and Implement Solutions to Improve Representation

There is often a mismatch between population demographics and participants in clinical trials. This can have a dire impact as the results of a trial may not be broadly applicable to all affected by the disease. Time, money and opportunity are lost.

The ongoing coronavirus pandemic further highlights this challenge. Many of the critically-ill patients are from ethnic minority backgrounds, and may not be participating in clinical trials at that same rate.

This interactive webinar featuring an esteemed panel of presenters will define diversity in clinical trials showcasing the regional, gender and socio-economic differences that impact representation in clinical trials.

Together, the panellists will encourage participants to make a difference in their communities and companies, finding ways to build trust and make clinical trials more inclusive.

Presented by

Angela LaRonde,

As Relationship Management Director, Angela strives to ensure Greenphire’s solutions and services continue to exceed client needs and drive innovation in the market. Angela has over 15 years of industry experience engaging with clients and technology to improve the clinical trial experience for all stakeholders.

Tamás Bereczky,

Tamás Bereczky currently works as the course coordinator, content developer and trainer of EUPATI The European Patients’ Academy for Therapeutic Innovation (www.eupati.eu). Before that, he was member of the European AIDS Treatment Group (www.eatg.org), the largest European network of individuals living with HIV for 15 years, also working as its communications officer between 2015 and 2018. HIV positive since 2003, he served as a member of the board of directors of the EATG for almost 4 years, and also served the co-chair of the European Commission’s Civil Society Forum on HIV/AIDS between 2013 and 2015. Tamás also works as a partner and consultant in the patient-led and focused strategic advisory Patvocates (www.patvocates.net).

Dr. Ingrid Klingmann,

Dr. Ingrid Klingmann is a doctor and an expert in clinical trials and ethics, she has been leading the European Forum for Good Clinical Practice (EFGCP) and was the initiator of the original idea behind EUPATI. She has been one of the key contributors and trainers of EUPATI for many years, and she is currently a Board member.

Dr. Ian Hodgson,

Dr. Ian Hodgson is an EATG member, a PhD in social sciences and nursing, specialising in HIV care in Africa and other challenging settings. Ian has been publishing about patient engagement and the HIV community for many years, his recent work has been a comprehensive landscape mapping of the response of the HIV community to the COVID pandemic.

Key Learning Objectives

  • Define diversity in clinical trials
  • Identify historical barriers to participation
  • Determine ways to reach hard to reach populations
  • Showcase inclusion success stories


  • Clinical Trial Design
  • Clinical Trial Execution
  • Clinical Trial Participation